Dandekar Atul sold MAZE
December 30, 2025 · Form 4 insider transaction
Dandekar Atul sold 100 shares of Maze Therapeutics, Inc. at $40.36 per share, a transaction worth $4.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$40.36
Total value
$4.0K
InsiderDandekar Atul
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 30, 2025
Filing dateDecember 31, 2025
Shares owned after10,503
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.